PACS Group, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds PACS Group, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit

Core Viewpoint - A securities class action lawsuit has been filed against PACS Group, Inc. for allegedly making materially false and misleading statements regarding its business operations and financial performance during the Class Period from April 11, 2024, to November 5, 2024 [5][6]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York on behalf of investors who purchased PACS common stock during its IPO and the subsequent Class Period [5]. - The lead plaintiff deadline for the lawsuit is set for January 13, 2025 [5][7]. Group 2: Allegations Against PACS - The complaint alleges that PACS engaged in fraudulent activities, including submitting false Medicare claims that accounted for over 100% of its operating and net income from 2020 to 2023 [6]. - Additional allegations include billing for unnecessary respiratory and sensory integration therapies to Medicare and falsifying documentation related to licensure and staffing [6]. Group 3: Investor Participation - PACS investors have the option to seek appointment as a lead plaintiff representative or remain absent class members, with the lead plaintiff typically being the investor with the largest financial interest [7].